CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Indivior Inc. v. Actavis Laboratories UT, Inc.

1:16-cv-01009

Overview

Case Number 1:16-cv-01009
Filing Date 2016-10-31
Status Terminated
Termination Date 2021-04-09
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Actavis Laboratories UT, Inc. Operating Company

Represented By

2 Attorneys Listed

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

MonoSol Rx. LLC Operating Company

Represented By

3 Attorneys Listed

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Indivior UK Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Indivior Inc. Operating Company

Represented By

3 Attorneys Listed

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 20 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (20): πŸ‡¨πŸ‡¦ Canada CN πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan KR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8475832
Sublingual and buccal film compositions
Filed: 2009-08-07
Issued: 2013-07-02
Active (3.3 yrs remaining) +231d PTA
Expires: 2030-03-26
US8017150
Polyethylene oxide-based films and drug delivery systems made therefrom
Filed: 2008-04-22
Issued: 2011-09-13
Expired (Term Ended)
Expires: 2023-10-10
US8603514
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
Filed: 2007-07-10
Issued: 2013-12-10
Expired (Term Ended)
Expires: 2024-04-03

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+231 days) / Cellect Scrutiny β€” Over 231 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(46 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Actavis Laboratories UT, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2022673.) - filed by Indivior Inc., MonoSol Rx. LLC, Indivior UK Limited. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(jcs) (Entered: 11/01/2016)

Entry #1 • 2016-10-31
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jcs) (Entered: 11/01/2016)

Entry #2 • 2016-10-31
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/19/2016. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/19/2019. (jcs) (Entered: 11/01/2016)

Entry #3 • 2016-10-31
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,475,832; 8,017,150; 8,603,514. (jcs) (Entered: 11/01/2016)

Entry #4 • 2016-10-31
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent RBP Global Holdings Ltd., Corporate Parent US Holdings Inc. for Indivior Inc. filed by Indivior Inc.. (jcs) (Entered: 11/01/2016)

Entry #5 • 2016-10-31
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc